New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 16, 2012
20:54 EDTACI, SWI, WFC, CAB, AAPL, JNJ, KITD, BAC, LEG, JPM, CLH, GOOG, MMM, ACAS, VOD, LVS, ECYT, DKS, CLNE, PFE, WYNNJim Cramer's "Mad Money"
Jim Cramer said that all of last month's winners got pummeled Monday, while a whole new class of stocks became 'en vogue'. He said for weeks, hedge fund managers have been betting hundreds of billions on continued weakness in Europe. So today, when the U.S. dollar reversed course and took a turn for the better, many managers were caught on the wrong side of the trade. That explains the action in many weak dollar stocks like 3M (MMM), Johnson & Johnson (JNJ) and Pfizer (PFE), said Cramer. These stocks, along with many of the banks, all saw their shares slide Monday. Then there are the Nasdaq darlings, Google (GOOG) and Apple (AAPL). Cramer said that while Google's slide was due to weak earnings and a questionable stock split, Apple's slide seems to be one in sympathy with the search engine giant. Cramer said there are many fund managers who would love to see shares of Apple lower, which explains many of the rumors swirling about telcos becoming unwilling to pay sky-high iPhone subsidies. He said the selling in Apple could also simply be investors taking profits to pay their taxes. But whatever the reasons for all of the selling in the markets, Cramer said the fact remains that high-quality growth stocks of all kinds are now on sale and remain a great place in which to invest. EXECUTIVE DECISION: Cramer checked back in with Andrew Littlefair, president and CEO of Clean Energy Fuels (CLNE), a stock that's up 61% since Cramer last spoke with Littlefair on Nov. 14. Cramer said that Clean Energy Fuels remains a speculative stock, adding that investors should do their homework before buying in. Cramer also spoke with Alan McKim, chairman, president and CEO of Clean Harbors (CLH), an environmental clean up company focused in the oil and natural gas industries. McKim once again touted Clean Harbors' incinerator business as a bright spot for the company. Cramer continued his recommendation of Clean Harbors. Cramer said that investors need to be able to pick the best stocks in a stock pickerís market. He compared Cabella's (CAB) to Dick's Sporting Goods (DKS) to find out which one reigns supreme in the hunting, fishing and sporting goods arena. According to Cramer, Cabella's has Dick's beat on store growth plans, same-store sales growth and higher private label sales. Also, the fact that its stock is cheap, trading at just 13x earnings compared to 17x for Dick's, makes things that much sweeter. NO HUDDLE OFFENSE: Cramer opined on earnings from JPMorgan Chase (JPM) and Wells Fargo (WFC). He said, earnings at these banks were superb. LIGHTNING ROUND: (Bullish) ECYT, LEG, SWI, LVS. (Bearish) BAC, ACI, VOD, KITD, WYNN, ACAS. Reference Link
News For MMM;JNJ;PFE;GOOG;AAPL;CLNE;CLH;CAB;DKS;JPM;WFC;ECYT;LEG;SWI;LVS;BAC;ACI;VOD;KITD;WYNN;ACAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>
February 23, 2015
05:29 EDTAAPLApple to invest EUR 1.6B in new European data centers
Subscribe for More Information
05:29 EDTMMMPolypore agrees to sell company for $60.50 per share
Subscribe for More Information
05:27 EDTAAPLApple to invest EUR 1.6B in new European data centers
February 22, 2015
17:11 EDTAAPLApple could reach $160 in a year, Barron's says
Subscribe for More Information
15:11 EDTAAPLApple increases capabilities in industrial lithium-ion batteries, Reuters says
Subscribe for More Information
12:51 EDTJNJJ&J considers Cordis sale with Cardinal the leading suitor, Bloomberg says
Subscribe for More Information
February 20, 2015
17:31 EDTJNJJ&J considering sale of Cordis with Cardinal the leading suitor, Bloomberg says
Subscribe for More Information
16:48 EDTAAPLDow, S&P 500 finish week at record highs after Greek deal reached
Subscribe for More Information
16:03 EDTJNJ, AAPLOptions Update; February 20, 2015
Subscribe for More Information
11:02 EDTAAPLApple electric car could be 'iPhone of the Future,' says Cantor
Cantor Fitzgerald analyst Brian White says he believes an electric car from Apple has the potential to be the "iPhone of the Future." White, in a note to investors today, added that he doubts Apple's reach will stop there. He believes the personal robot category offers "great potential over the next decade and fits well with Apple's skill set." White thinks the reports of an electric car show innovation at the tech giant continues. He keeps a Buy rating Apple shares with a $160 price target. The stock is up 30c it morning trading to $128.71.
11:00 EDTAAPLApple electric car could be 'iPhone of the Future,' sys Cantor
Subscribe for More Information
10:33 EDTPFEBattleground update: AbbVie named top global pick at Jefferies
Subscribe for More Information
10:31 EDTPFEPfizer announces FDA acceptance of NDA for Rapamune
Pfizer announced that the FDA has accepted for priority review a supplemental New Drug Application for RAPAMUNE for the treatment of lymphangioleiomyomatosis, a rare, progressive lung disease in women of childbearing age that is often fatal. With the Priority Review designation for the sNDA, Pfizer anticipates a decision in June of 2015 based on the anticipated Prescription Drug User Fee Act action date. The sNDA is based on results from the Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus Trial. The MILES Trial included 89 LAM patients with moderate lung impairment who were randomized to receive RAPAMUNE or placebo for 12 months, followed by a 12 month observation period. In the trial, those treated with RAPAMUNE for one year experienced stabilization of lung function as measured by forced expiratory volume in one second.
09:38 EDTAAPL, JNJActive equity options trading on open
Subscribe for More Information
07:42 EDTGOOGFDA authorizes 23andMe to market genetic testing for Bloom Syndrome
The U.S. Food and Drug Administration yesterday authorized for marketing Google-backed 23andMeís Bloom Syndrome carrier test, a direct-to-consumer genetic test to determine whether a healthy person has a variant in a gene that could lead to their offspring inheriting the serious disorder. Along with this authorization, the FDA is also classifying carrier screening tests as class II. In addition, the FDA intends to exempt these devices from FDA premarket review. The agency plans to issue a notice that announces the intent to exempt these tests and that provides a 30-day period for public comment.
07:23 EDTJNJ, PFEAbbVie replaces Pfizer as top global pharma pick at Jefferies
Subscribe for More Information
06:41 EDTAAPLApple pushing for 2020 production of its electric car, Bloomberg says
Apple (AAPL) is pushing to begin production of its electric vehicle as soon as 2020, reports Bloomberg, citing people with knowledge of the matter. Bloomberg notes that the move could put Apple into direct competition with Tesla (TSLA) and General Motors (GM), both of which are targeting a 2017 release for next-generation electric vehicles. Apple may still cancel the project if it becomes unhappy with progress, the sources said, though its vehicle team is already 200-people strong. Reference Link
06:22 EDTGOOGYouTube to release stand-alone app for kids, WSJ says
Google's YouTube is planning to release a smartphone and tablet app for kids featuring original episodes of television shows including "Thomas the Tank Engine" and "Sesame Street," as well as content from existing YouTube kids channels, reports the Wall Street Journal, citing a person familiar with the matter. The app -- slated for an official reveal Monday at the Kidscreen Summit -- will initially only be available for Android devices. The source said the inclusion of ads is "under discussion." Reference Link
06:20 EDTAAPLApple price target raised to $145 on increasingly bullish outlook at Goldman
Goldman raised Buy rated Apple's price target to $145 from $130 based on increased confidence in platform momentum, sustained iPhone growth, and the potential for the Apple Watch. The firm believes risk/reward is more balanced following the recent 20% upside move but sees further upside given the aforementioned factors and the near-term catalysts from the April watch launch, updates on capital allocation, and a likely March quarter beat.
06:03 EDTJPMAnn Inc. working with JPMorgan on potential sale, Bloomberg reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use